Drug Shortage Report for DEPO-PROVERA

Last updated on 2021-07-22 History

Report ID	131486
Drug Identification Number	00585092
Brand name	DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML
Common or Proper name	DEPO-PROVERA
Company Name	PFIZER CANADA ULC
Market Status	MARKETED
Active Ingredient(s)	MEDROXYPROGESTERONE ACETATE
Strength(s)	150MG
Dosage form(s)	SUSPENSION
Route of administration	INTRAMUSCULAR INTRAMUSCULAR
Packaging size	1 x 1ML
ATC code	G03AC
ATC description	HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage	Disruption of the manufacture of the drug.
Anticipated start date	2021-07-23
Actual start date	2021-07-21
Estimated end date	2022-06-01
Actual end date
Shortage status	Actual shortage
Updated date	2021-07-22
Company comments	Other presentation available: US-labelled pre-filled syringes We do not anticipate a gap in supply of DEPO-PROVERA on the Canadian market in 2021-2022.
Health Canada comments
Contact Address	17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5
Company contact information	Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.